Tabula Rasa HealthCare (TRHC) Misses Q2 EPS by 19c

Tabula Rasa HealthCare (NASDAQ: TRHC) reported Q2 EPS of ($0.38), $0.19 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $90 million versus the consensus estimate of $88.87 million.

GUIDANCE:

Tabula Rasa HealthCare sees Q2 2023 revenue of $88-90 million, versus the consensus of $91.053 million.

For earnings history and earnings-related data on Tabula Rasa HealthCare (TRHC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c